These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 15047125)

  • 1. CD9 expression in gastric cancer and its significance.
    Hori H; Yano S; Koufuji K; Takeda J; Shirouzu K
    J Surg Res; 2004 Apr; 117(2):208-15. PubMed ID: 15047125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Motility-related protein (MRP-1/CD9) and KAI1/CD82 expression inversely correlate with lymph node metastasis in oesophageal squamous cell carcinoma.
    Uchida S; Shimada Y; Watanabe G; Li ZG; Hong T; Miyake M; Imamura M
    Br J Cancer; 1999 Mar; 79(7-8):1168-73. PubMed ID: 10098753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study on association between the expression of galectin- 3 and the peritoneal metastasis in gastric cancer].
    Yang ZM; Wu XT; He T; Da MX; Luo T; Qian K
    Zhonghua Wei Chang Wai Ke Za Zhi; 2005 Mar; 8(2):151-4. PubMed ID: 16155829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear localization of annexin A1 correlates with advanced disease and peritoneal dissemination in patients with gastric carcinoma.
    Zhu F; Xu C; Jiang Z; Jin M; Wang L; Zeng S; Teng L; Cao J
    Anat Rec (Hoboken); 2010 Aug; 293(8):1310-4. PubMed ID: 20665809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oct4, a novel marker for human gastric cancer.
    Chen Z; Xu WR; Qian H; Zhu W; Bu XF; Wang S; Yan YM; Mao F; Gu HB; Cao HL; Xu XJ
    J Surg Oncol; 2009 Jun; 99(7):414-9. PubMed ID: 19347886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression of Ezrin in gastric carcinoma and its significance].
    Shi RL; Li JF; Qu Y; Chen XH; Gu QL; Zhu ZG; Liu BY
    Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Sep; 9(5):433-5. PubMed ID: 17043968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of CD9 expression in locally advanced gastric cancer treated with surgery and adjuvant chemoradiotherapy.
    Soyuer S; Soyuer I; Unal D; Ucar K; Yildiz OG; Orhan O
    Pathol Res Pract; 2010 Sep; 206(9):607-10. PubMed ID: 20547009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas.
    Zheng HC; Takahashi H; Li XH; Hara T; Masuda S; Guan YF; Takano Y
    Hum Pathol; 2008 Jul; 39(7):1042-9. PubMed ID: 18482745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ets-1 expression in gastric cancer.
    Tsutsumi S; Kuwano H; Nagashima N; Shimura T; Mochiki E; Asao T
    Hepatogastroenterology; 2005; 52(62):654-6. PubMed ID: 15816498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of osteopontin expression in human gastric carcinoma.
    Higashiyama M; Ito T; Tanaka E; Shimada Y
    Ann Surg Oncol; 2007 Dec; 14(12):3419-27. PubMed ID: 17896150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wnt pathway is involved in advanced gastric carcinoma.
    Zhang H; Xue Y
    Hepatogastroenterology; 2008; 55(84):1126-30. PubMed ID: 18705344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Down-regulation of caveolin-1 in gastric carcinoma and its clinical biological significance].
    Gao X; Sun Y; Huang L; Chen XY; Zhang KL; Kong QY; Liu J; Li H
    Ai Zheng; 2005 Mar; 24(3):311-6. PubMed ID: 15757532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A comparative study of E-cadherin mRNA expression in primary tumors and metastatic foci of gastric cancer].
    Yang J; Dai DQ
    Zhonghua Zhong Liu Za Zhi; 2005 Jan; 27(1):25-8. PubMed ID: 15771793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of KAI1 expression in gastric cancer.
    Tsutsumi S; Shimura T; Morinaga N; Mochiki E; Asao T; Kuwano H
    Hepatogastroenterology; 2005; 52(61):281-4. PubMed ID: 15783050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Motility related protein 1 (MRP1/CD9) expression in colon cancer.
    Mori M; Mimori K; Shiraishi T; Haraguchi M; Ueo H; Barnard GF; Akiyoshi T
    Clin Cancer Res; 1998 Jun; 4(6):1507-10. PubMed ID: 9626469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of tumor marker CDw75 and its clinical impact in gastric carcinoma].
    Li HX; Shen ZX; Tan SY
    Ai Zheng; 2003 Jan; 22(1):83-5. PubMed ID: 12561443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Motility related protein 1 (MRP-1/CD9) expression: inverse correlation with metastases in breast cancer.
    Miyake M; Nakano K; Ieki Y; Adachi M; Huang CL; Itoi S; Koh T; Taki T
    Cancer Res; 1995 Sep; 55(18):4127-31. PubMed ID: 7664290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations of APC, c-met, and p53 genes in tumor tissue and serum of patients with gastric cancers.
    Wang JY; Hsieh JS; Chen CC; Tzou WS; Cheng TL; Chen FM; Huang TJ; Huang YS; Huang SY; Yang T; Lin SR
    J Surg Res; 2004 Aug; 120(2):242-8. PubMed ID: 15234219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of CD9 expression during prostate carcinoma progression is associated with CD9 mRNA modifications.
    Wang JC; Bégin LR; Bérubé NG; Chevalier S; Aprikian AG; Gourdeau H; Chevrette M
    Clin Cancer Res; 2007 Apr; 13(8):2354-61. PubMed ID: 17406028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of CD9 in human ovarian carcinoma cell might contribute to peritoneal dissemination: morphologic alteration and reduced expression of beta1 integrin subsets.
    Furuya M; Kato H; Nishimura N; Ishiwata I; Ikeda H; Ito R; Yoshiki T; Ishikura H
    Cancer Res; 2005 Apr; 65(7):2617-25. PubMed ID: 15805258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.